Safety endpoints included the number of treatment-emergent adverse events (AEs) and the number of hypoglycaemic episodes up to approximately 31 weeks, defined according to the three-tier ADA 2018 classification [23], and the change from baseline to week 26 in laboratory assessments and vital signs
Research continues to show that intestinal permeability plays a role in triggering and perpetuating autoimmune conditions
Analyze its meaning, calculation method, and factors affecting the variation of C rating in different battery types
The total extension period cannot exceed five years, and the total effective patent life after FDA approval is limited to 14 years
The Regulatory Pathway to Market Leadership The regulatory journey for retatrutide represents a fascinating case study in how breakthrough therapies navigate the complex approval process while building the evidence base needed for broad clinical adoption and market success
and risk of prostate cancerplus a more elevated risk of liver damage than with injectable steroids
